Amcor (AMCR) has opened a new healthcare packaging coating facility in Subang Jaya, Selangor, committing over US$35 million to air knife coated medical paper production for sterile medical device packaging.

Despite opening the new Malaysian facility and partnering on fiber based food packaging, Amcor’s recent share price momentum has been weak, with a 30 day share price return of 5.46% and a 1 year total shareholder return of 14.19%.

If you are weighing Amcor’s recent moves against other opportunities in packaging and industrial supply chains, this could be a good time to scan 17 top founder-led companies

With the share price under pressure and some valuation models suggesting a discount to intrinsic value and analyst targets, should you see Amcor as undervalued today, or assume the market is already pricing in its future growth potential?

Most Popular Narrative: 655% Overvalued

According to the narrative by andy_c, Amcor’s fair value sits at $5.00 per share, far below the last close of $37.75, which creates a wide valuation gap for investors to judge.

Relative to the three valuation methods, the stock looks overvalued versus DCF but undervalued versus P/B, producing a wide margin of safety range from negative 70% to positive 35%.​

Curious why one framework points to a steep premium while another suggests asset based value support? The narrative leans on earnings power, cash generation and balance sheet strength to reconcile that spread. The tension sits in how future profitability, capital structure and payout plans are expected to evolve from here.

Result: Fair Value of $5.00 (OVERVALUED)

However, this view of overvaluation could be challenged if Amcor’s US$19.6b revenue base and US$596m net income support stronger cash generation, or if analyst targets around $50.22 gain traction.

Another View: DCF Signals Undervaluation

That 655% overvaluation call sits in sharp contrast to the Simply Wall St DCF view. At a last close of $37.75, the shares are trading 49.5% below an estimated future cash flow value of $74.75. This frames Amcor as undervalued instead of overpriced. So which story do you trust when cash flows and multiples disagree?

To understand how this cash flow based estimate is built and what would need to change for the valuation to shift, take a closer look at the SWS DCF model, Look into how the SWS DCF model arrives at its fair value.

Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Amcor for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 50 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.

Next Steps

Torn between the mixed signals in this story? Act now and check the full picture of upside and downside in 3 key rewards and 4 important warning signs

Looking for more investment ideas?

If Amcor does not quite fit your plan, broaden your search now so you do not miss other companies that align better with your goals.

• Target potential value opportunities by screening companies that combine quality fundamentals with attractive pricing using the 50 high quality undervalued stocks.
• Strengthen your income focus by zeroing in on companies with yields from robust payout profiles through the 13 dividend fortresses.
• Lower portfolio stress by concentrating on companies with steadier financial risk profiles using the 69 resilient stocks with low risk scores.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.